A LinkedIn post from bwell Connected Health highlights findings from Rock Health’s 2025 survey indicating rapid consumer adoption of AI tools for health information. The post notes that 32% of consumers now use AI for health information, reportedly double last year, and that 81% of those users take direct action after interacting with a chatbot.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests a widening gap between cautious healthcare institutions and faster-moving consumers who are turning to general-purpose large language models. It characterizes this as a shift in the clinician‑patient power dynamic and positions health innovators as responsible for creating “safe, clinical on‑ramps” that channel consumer AI use into appropriate care.
According to the post, bwell Connected Health aims to “bridge this gap” by converting AI-driven health interactions into navigated care supported by comprehensive health data. The company frames this as infrastructure that allows traditional healthcare systems and consumer-led AI usage to operate in tandem rather than in opposition.
The post includes a quote from CEO Kristen Valdes emphasizing that patients are unlikely to stop using AI tools because they fill a “real gap,” and that stakeholders have an obligation to improve this technology responsibly. For investors, this positioning may indicate that bwell is targeting demand at the intersection of consumer AI behavior, data integration, and care navigation, potentially enhancing its relevance to payers and providers seeking safe ways to harness patient-led AI usage.
If bwell can effectively operationalize these concepts into scalable products and partnerships, it could benefit from early-mover advantages in AI-enabled care navigation. However, the post does not provide details on revenue impact, customer contracts, or regulatory considerations, so the financial implications remain uncertain and depend on execution, adoption by enterprise clients, and evolving oversight of AI in healthcare.